Arkolith/Insider Trading/INDP/Form 4

Meckler Jeffrey A

CEO and Director, DirectorIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Nov 22, 2022
Net Buying
Open-Market Buys
$19K
Open-Market Sells
$0
Net Open-Market Flow
$19K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2022Buy(P)10K$1.90$18K75K
Nov 18, 2022Buy(P)400$1.76$70466K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-033241) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML